rs765542916

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2

The NM_001122630.2(CDKN1C):​c.719C>T​(p.Ala240Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000464 in 1,358,790 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A240T) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.000046 ( 0 hom. )

Consequence

CDKN1C
NM_001122630.2 missense

Scores

3
1
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:1

Conservation

PhyloP100: 4.75

Publications

0 publications found
Variant links:
Genes affected
CDKN1C (HGNC:1786): (cyclin dependent kinase inhibitor 1C) This gene is imprinted, with preferential expression of the maternal allele. The encoded protein is a tight-binding, strong inhibitor of several G1 cyclin/Cdk complexes and a negative regulator of cell proliferation. Mutations in this gene are implicated in sporadic cancers and Beckwith-Wiedemann syndorome, suggesting that this gene is a tumor suppressor candidate. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]
CDKN1C Gene-Disease associations (from GenCC):
  • Beckwith-Wiedemann syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • IMAGe syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Illumina, G2P, Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • Beckwith-Wiedemann syndrome due to CDKN1C mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intrauterine growth restriction-short stature-early adult-onset diabetes syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Silver-Russell syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.22673956).
BS1
Variant frequency is greater than expected in population eas. GnomAdExome4 allele frequency = 0.0000464 (63/1358790) while in subpopulation EAS AF = 0.000609 (19/31196). AF 95% confidence interval is 0.000398. There are 0 homozygotes in GnomAdExome4. There are 31 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAdExome4 at 63 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKN1CNM_001122630.2 linkc.719C>T p.Ala240Val missense_variant Exon 2 of 4 ENST00000440480.8 NP_001116102.1 P49918-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKN1CENST00000440480.8 linkc.719C>T p.Ala240Val missense_variant Exon 2 of 4 1 NM_001122630.2 ENSP00000411257.2 P49918-2

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.0000124
AC:
2
AN:
161904
AF XY:
0.0000108
show subpopulations
Gnomad AFR exome
AF:
0.000141
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000134
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000464
AC:
63
AN:
1358790
Hom.:
0
Cov.:
31
AF XY:
0.0000459
AC XY:
31
AN XY:
675944
show subpopulations
African (AFR)
AF:
0.000179
AC:
5
AN:
27956
American (AMR)
AF:
0.00
AC:
0
AN:
35698
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23334
East Asian (EAS)
AF:
0.000609
AC:
19
AN:
31196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79034
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35492
Middle Eastern (MID)
AF:
0.000390
AC:
2
AN:
5122
European-Non Finnish (NFE)
AF:
0.0000347
AC:
37
AN:
1065652
Other (OTH)
AF:
0.00
AC:
0
AN:
55306
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.00000910
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Beckwith-Wiedemann syndrome Uncertain:2
Jul 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 251 of the CDKN1C protein (p.Ala251Val). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with CDKN1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 575298). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CDKN1C protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Oct 25, 2023
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Jul 16, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.752C>T (p.A251V) alteration is located in exon 1 (coding exon 1) of the CDKN1C gene. This alteration results from a C to T substitution at nucleotide position 752, causing the alanine (A) at amino acid position 251 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Beckwith-Wiedemann syndrome;C1846009:IMAGe syndrome Benign:1
Apr 17, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
0.0027
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.071
T;T;.
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.38
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.56
.;T;T
M_CAP
Pathogenic
0.94
D
MetaRNN
Benign
0.23
T;T;T
MetaSVM
Benign
-0.39
T
MutationAssessor
Benign
0.69
N;N;.
PhyloP100
4.7
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-1.2
N;N;N
REVEL
Benign
0.24
Sift
Pathogenic
0.0
D;D;D
Sift4G
Benign
0.20
T;T;T
Polyphen
0.99
D;D;.
Vest4
0.17
MutPred
0.28
Loss of helix (P = 0.079);Loss of helix (P = 0.079);.;
MVP
0.51
MPC
1.3
ClinPred
0.31
T
GERP RS
1.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.12
gMVP
0.13
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs765542916; hg19: chr11-2905968; API